Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma

Diagnostic Cytopathology

Volumn 38, Issue 11, 2010, Pages 788-790

  Arora, Vinod Kumar ^a   Sarungbam, Judy ^a   Bhatia, Arati ^a   Singh, Navjeevan ^a   Agrawal, Vivek ^a   Aggarwal, Seema ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

atypical urothelial cells; NMP; urine cytology; urothelial carcinoma

Indexed keywords

NUCLEAR MATRIX PROTEIN 22;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINE CYTOLOGY;

CARCINOMA, TRANSITIONAL CELL; CYTODIAGNOSIS; HUMANS; NUCLEAR PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 78349252292     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21286     Document Type: Article

References (15)

1. Kroft SH, Oyasu R,. Urinary bladder cancer: Mechanisms of development and progression. Lab Invest 1994; 7: 158 -174.
2. Renshaw AA, Nappi D, Weinberg DS,. Cytology of grade I papillary transitional carcinoma: A comparison of cytologic, architectural, and morphometric criteria in cystoscopically obtained urine. Acta Cytol 1996; 40: 676 -682.
3. Renshaw AA,. Sub classifying atypical urinary cytology specimens. Cancer 2000; 90: 222 -229.
4. Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I,. Noninvasive detection of bladder cancer with the BTA stat test. J Urol 1999; 161: 443 -446.
5. Mansoor I, Calam RR, Al-Khafaji B,. Role of urinary NMP-22 combined with urine cytology in follow-up surveillance of recurring superficial bladder urothelial carcinoma. Anal Quant Cytol Histol 2008; 30: 25 -32.
6. Gupta NP, Sharma N, Kumar R,. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder. Urology 2009; 73: 592 -596.
7. Berezney R, Coffey DS,. Identification of nuclear protein matrix. Biochem Res Commun 1974; 60: 1410 -1417.
8. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE,. A prospective analysis of 1930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000; 163: 524 -527.
9. Nabi G, Greene DR, O'Donnell M,. How important is urine cytology in the diagnosis of urological malignancies? Eur Urol 2003; 43: 632 -636.
10. Koss LG,. Tumors of the urinary tract in urine and Brushings. In:, Koss LG, Melamed MR, editors. Koss'diagnostic cytology and its histopathologic bases. Philadelphia: Lippincot; 2006. p 780 -799.
11. Koss LG, Deitch D, Ramanathan R, Sherman AB,. Diagnostic value of cytology of voided urine. Acta Cytol 1985; 29: 810 -816.
12. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS,. Urine cytology and bladder cancer: The cellular features of transitional cell neoplasms. Cancer 1984; 53: 1555 -1565.
13. Shenoy UA, Colby TV, Schumann GB,. Reliability of urine cytodiagnosis in urothelial neoplasm. Cancer 1985; 56: 2041 -2045.
14. Soloway MS, Briggman JV, Carpinito GA, et al. Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 1996; 156: 363 -367.
15. Miyanaga N, Akaza H, Ishikawa S, et al. Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur Urol 1997; 31: 163 -168.